EP0880320A4 - Inhibiteurs de la farnesyl-proteine transferase - Google Patents

Inhibiteurs de la farnesyl-proteine transferase

Info

Publication number
EP0880320A4
EP0880320A4 EP97904147A EP97904147A EP0880320A4 EP 0880320 A4 EP0880320 A4 EP 0880320A4 EP 97904147 A EP97904147 A EP 97904147A EP 97904147 A EP97904147 A EP 97904147A EP 0880320 A4 EP0880320 A4 EP 0880320A4
Authority
EP
European Patent Office
Prior art keywords
farnesyl
inhibitors
protein transferase
transferase
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97904147A
Other languages
German (de)
English (en)
Other versions
EP0880320A1 (fr
Inventor
Christopher J Dinsmore
George D Hartman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605699.9A external-priority patent/GB9605699D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0880320A1 publication Critical patent/EP0880320A1/fr
Publication of EP0880320A4 publication Critical patent/EP0880320A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP97904147A 1996-01-30 1997-01-27 Inhibiteurs de la farnesyl-proteine transferase Withdrawn EP0880320A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1086096P 1996-01-30 1996-01-30
US10860P 1996-01-30
GB9605699 1996-03-19
GBGB9605699.9A GB9605699D0 (en) 1996-03-19 1996-03-19 Inhibitors of farnesyl-protein transferase
PCT/US1997/001599 WO1997027752A1 (fr) 1996-01-30 1997-01-27 Inhibiteurs de la farnesyl-proteine transferase

Publications (2)

Publication Number Publication Date
EP0880320A1 EP0880320A1 (fr) 1998-12-02
EP0880320A4 true EP0880320A4 (fr) 1999-06-16

Family

ID=26308951

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97904147A Withdrawn EP0880320A4 (fr) 1996-01-30 1997-01-27 Inhibiteurs de la farnesyl-proteine transferase

Country Status (4)

Country Link
EP (1) EP0880320A4 (fr)
AU (1) AU712504B2 (fr)
CA (1) CA2243507A1 (fr)
WO (1) WO1997027752A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929250A (en) * 1997-01-23 1999-07-27 Smithkline Beecham Corporation IL-8 receptor antagonists
JP2002519376A (ja) 1998-07-02 2002-07-02 メルク エンド カムパニー インコーポレーテッド プレニル蛋白トランスフェラーゼ阻害薬
AU760028B2 (en) 1998-07-02 2003-05-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
FR2780892B1 (fr) * 1998-07-08 2001-08-17 Sod Conseils Rech Applic Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique
US6331541B1 (en) 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6525069B1 (en) 1998-12-18 2003-02-25 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
IL142768A0 (en) 1998-12-18 2002-03-10 Du Pont Pharm Co N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2056700A (en) 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
CA2347909A1 (fr) 1998-12-18 2000-06-22 Joseph B. Santella, Iii N-ureidoalkyl-piperidines utilisees en tant que modulateurs de l'activite des recepteurs des chimiokines
EP1140087A4 (fr) 1998-12-18 2002-04-03 Du Pont Pharm Co N-ureidoalkyl-piperidines utilisees en tant que modulateurs de l'activite des recepteurs des chimiokines
US6897234B2 (en) 1999-12-17 2005-05-24 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2001251444A1 (en) 2000-04-10 2001-10-23 Merck And Co., Inc. Inhibitors of prenyl-protein transferase
DE10025782A1 (de) 2000-05-26 2001-12-06 Basf Ag Flüssigkristalline Stoffgemenge
EP1162194A1 (fr) * 2000-06-06 2001-12-12 Aventis Pharma Deutschland GmbH Dérivés de (thio)-urée inhibiteurs du facteur VIIa, procédé de leur préparation et leur utilisation
US6627629B2 (en) 2000-06-30 2003-09-30 Bristol-Myers Squibb Pharma N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
AU2002326948A1 (en) 2001-09-18 2003-04-01 Bristol-Myers Squibb Company Piperizinones as modulators of chemokine receptor activity
TW200409630A (en) 2002-09-12 2004-06-16 Bristol Myers Squibb Co N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
WO2004028530A1 (fr) 2002-09-26 2004-04-08 Bristol-Myers Squibb Company Amines heterocycliques n-substituees, utilisees comme modulateurs de l'activite des recepteurs des chimiokines
AU2003259007A1 (en) 2002-10-31 2004-05-25 Amersham Biosciences Ab Use of urea variants as affinity ligands
EP2095819A1 (fr) 2008-02-28 2009-09-02 Maastricht University Dérivés de N-benzyle imidazole et leur utilisation comme inhibiteurs de l'aldosterone synthase

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010034A2 (fr) * 1994-09-29 1996-04-04 Merck & Co., Inc. Inhibiteurs de la transferase de proteines farnesylees exempts de thiol
WO1996039137A1 (fr) * 1995-06-06 1996-12-12 Merck & Co., Inc. Inhibiteurs de la farnesyl transferase
WO1997018813A1 (fr) * 1995-11-22 1997-05-29 Merck & Co., Inc. Inhibiteurs de la farnesyl-proteine transferase
WO1997027854A1 (fr) * 1996-01-30 1997-08-07 Merck & Co., Inc. Inhibiteurs de la farnesyl-proteine transferase
WO1997027853A1 (fr) * 1996-01-30 1997-08-07 Merck & Co., Inc. Inhibiteurs de farnesyl-proteine transferase
WO1997027852A1 (fr) * 1996-01-30 1997-08-07 Merck & Co., Inc. Inhibiteurs de la farnesyle transferase
WO1997036876A1 (fr) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibiteurs de la farnesyl-proteine transferase
WO1997036583A1 (fr) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibiteurs de la farnesyle-proteine transferase
WO1997036892A1 (fr) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibiteurs de farnesyle-proteine transferase
WO1997036584A1 (fr) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibiteurs de transferase de farnesyl-proteine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576957A (en) * 1984-07-05 1986-03-18 American Cyanamid Company N-(Substituted phenyl)-N'-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)alkyl]ureas
US5576293A (en) * 1993-09-30 1996-11-19 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
HUT72440A (en) * 1994-03-31 1996-04-29 Bristol Myers Squibb Co Imidazole-containing inhibitors of farnesyl protein transferase and pharmaceutical compositions containing them

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010034A2 (fr) * 1994-09-29 1996-04-04 Merck & Co., Inc. Inhibiteurs de la transferase de proteines farnesylees exempts de thiol
WO1996039137A1 (fr) * 1995-06-06 1996-12-12 Merck & Co., Inc. Inhibiteurs de la farnesyl transferase
WO1997018813A1 (fr) * 1995-11-22 1997-05-29 Merck & Co., Inc. Inhibiteurs de la farnesyl-proteine transferase
WO1997027854A1 (fr) * 1996-01-30 1997-08-07 Merck & Co., Inc. Inhibiteurs de la farnesyl-proteine transferase
WO1997027853A1 (fr) * 1996-01-30 1997-08-07 Merck & Co., Inc. Inhibiteurs de farnesyl-proteine transferase
WO1997027852A1 (fr) * 1996-01-30 1997-08-07 Merck & Co., Inc. Inhibiteurs de la farnesyle transferase
WO1997036876A1 (fr) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibiteurs de la farnesyl-proteine transferase
WO1997036583A1 (fr) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibiteurs de la farnesyle-proteine transferase
WO1997036892A1 (fr) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibiteurs de farnesyle-proteine transferase
WO1997036584A1 (fr) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibiteurs de transferase de farnesyl-proteine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9727752A1 *

Also Published As

Publication number Publication date
AU712504B2 (en) 1999-11-11
WO1997027752A1 (fr) 1997-08-07
AU1851697A (en) 1997-08-22
CA2243507A1 (fr) 1997-08-07
EP0880320A1 (fr) 1998-12-02

Similar Documents

Publication Publication Date Title
EP0891350A4 (fr) Inhibiteurs de farnesyle-proteine transferase
EP1011669A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
GB9604311D0 (en) Inhibitors of farnesyl-protein transferase
EP0891360A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
EP1045844A4 (fr) Inhibiteurs de farnesyl-proteine transferase
EP0904080A4 (fr) Inhibiteurs de farnesyle-proteine transferase
EP0880320A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
EP0891349A4 (fr) Inhibiteurs de farnesyl-proteine transferase
EP0891352A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
EP1035852A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
EP1035850A4 (fr) Inhibiteurs de la transferase de la farnesyl-proteine
EP0891335A4 (fr) Inhibiteurs de transferase de farnesyl-proteine
EP0891353A4 (fr) Inhibiteurs de farnesyle-proteine transferase
EP0959883A4 (fr) Inhibiteurs de la farnesyle-proteine transferase
EP1035849A4 (fr) Inhibiteurs de la transferase de la farnesyl-proteine
EP0877610A4 (fr) Inhibiteurs de farnesyl-proteine transferase
EP1023270A4 (fr) Inhibiteurs de farnesyl-proteine transferase
EP0900081A4 (fr) Inhibiteurs de farnesyl-proteine transferase
GB9721000D0 (en) Inhibitors of farnesyl-protein transferase
GB9624169D0 (en) Inhibitors of farnesyl-protein transferase
GB9617258D0 (en) Inhibitors of farnesyl-protein transferase
GB9610654D0 (en) Inhibitors of farnesyl-protein transferase
GB9609666D0 (en) Inhibitors of farnesyl-protein transferase
GB9607124D0 (en) Inhibitors of farnesyl-protein transferase
GB9609667D0 (en) Inhibitors of farnesyl-protein transferase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980831

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

RHK1 Main classification (correction)

Ipc: C07D233/54

A4 Supplementary search report drawn up and despatched

Effective date: 19990503

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20010906

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020117